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Metastasis consists of complex cascades and a lot of factors are involved in each step of metastasis. In recent studies, the role of 
epithelial-mesenchymal transition (EMT) in metastasis is suggested. EMT has a feature of epithelial cells conversing into mesenchymal 
cells morphologically and phenotypically, is a characteristic of malignant and metastatic cells in most cancer. The mesenchymal cells 
usually show more malignant phenotype, including invasion and metastasis. EMT can play an important role in metastasis of oral 
squamous cell carcinoma (OSCC). Although the role of Snail, slug, other transcriptional factors and E-cadherin are well known in 
human cancers, there are a few studies on N-cadherin and Twist expression in OSCC. The present study was aimed to analyze the 
expression of N-cadherin and Twist protein in OSCC from Korean patients. The immunohistochemical stain was performed using 58 pri-
mary OSCCs and 6 metastatic OSCCs, and the correlation between the expression of these proteins and clinicopathological parameters of 
OSCC patients was analyzed.
The expression rate of high expression of N-cadherin was observed in 70.4% and Twist in 87.3% of OSCC. The expression of 
N-cadherin in metastatic OSCC increased than in corresponding primary OSCC (p<0.05). The spearman correlation coefficiency be-
tween N-cadherin and Twist was calculated as 0.228. The clinical factors such as lymph node metastasis and survival showed statisti-
cally significant correlation between N-cadherin expression. The expression of Twist was correlated with recurrence. In conclusion, 
the authors suggest that N-cadherin may play an important role in malignant behaviour of OSCC and can be considered as prog-
nostic indicator of OSCC.
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Ⅰ. Introduction
Oral squamous cell carcinoma (OSCC), is one of the 
common cancers of the head and neck region1). The 
annual incidence of oral cancer is estimated at around 
275,000 with OSCCs representing >90% of these cases2). 
In spite of rapid advances in surgical and radiation 
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therapies for oral cancer, the 5-year survival rate and 
prognosis of OSCC patients remains relatively poor3,4). In 
addition, lymph node metastasis is an important 
determinant in the prognosis of OSCC4). Thus, it is very 
important to identify the factors that were related with 
the metastatic progression of OSCC in order to restrain 
the progression and improve the treatment strategies for 
oral cancer.
Recent researches suggested that epithelial-mesenchymal 
transition (EMT) might play an important role in the 
carcinoma progression and aggressiveness5,6). EMT describes 
a process in which epithelial cells lose their polarity and 
cell-cell junction and the properties of mesenchymal cell 
express through the cell changes of phenotype7). The 
hallmark of EMT is a cadherin switching, means that the 
normal expression of E-cadherin is replaced by the 
abnormal expression of N-cadherin or E-cadherin expression 
does not change but the expression of N-cadherin increases7,8).
N-cadherin was first identified in the brain of mouse as 
cadherin-28). It is normally expressed in neuroectodermal 
tissue, mesodermal-derived tissue such as nervous tissue, 
vascular endothelial cells, and skeletal and cardiac 
muscle cells but not normally in epithelial cells8,9). 
Throughout embryogenesis, N-cadherin is involved in the 
process of cell differentiation, migration, invasion and 
signal transduction9). In contrast, during tumor EMT 
process, a cadherin switch from E-cadherin to N-cadherin 
expression may enhance tumor aggressiveness10). Recent 
studies indicated that N-cadherin expression in tumor 
cells was associated with an increased tumor cell 
migration, invasiveness, metastasis, and drug sensitivities11). 
However, in OSCC, the expression of N-cadherin and the 
relation between the transcritptional factor involved in 
Cadherin switching is not elucidated. 
Twist, a highly conserved basic helix-loop-helix (bHLH) 
transcriptional factor, which is involved in the regulation 
of Cadherin, may play an important role in EMT-related 
metastasis through the regulation of cadherin expression12). 
During EMT process, there was change of several 
transcriptional factors expression such as Twist, Snail, 
and Slug and Cadherins13). Furthermore, Twist- enhanced 
cancer metastasis in breast, gastric, and hepatocellular 
carcinoma was reported14). 
In the present study, the authors investigated the role 
of N-cadherin and Twist protein in primary and metastatic 
OSCC. Furthermore, we compared the relationships between 
immunohistochemical scores and clinicopathological para- 
meters to examine the pathological role of N-cadherin 
and Twist expression in Korean OSCC patients.
Ⅱ. MATERIALS AND METHODS
1. Patients and tissue samples 
Fifty-eight cases of primary OSCC and 6 cases of me- 
tastatic OSCC with good preservation of paraffin tissue 
and H/E slides were obtained from the files of 
Department of Pathology, Medical College, Pusan National 
University and Department of oral pathology Yonsei 
University College of Dentistry from January 2001 to 
December 2007. 
The authorization of using the tissues for research was 
obtained from the Institutional Review Board in Pusan 
National University Hospital.
2. The clinicopathological characteristics of 
OSCC patients 
Clinical data of OSCC patients were gathered from 
surgical records of the patients. Clinicopathological cha- 
racteristics of OSCC patients were summarized in Table 1.
3. H/E stain and immunohistochemical stain
The OSCC tissue were fixed in 10% neutral formalin 
23
Table 1. Primary antibodies for immunohistochemical studies 
Antibody Dilution ratio Clonality Source
N-cadhrein 1:200 Polyclonal BD Biosciences a
Twist 1:150 Polyclonal Abcam b
*aBD Biosciences, Bedford, MA, USA
*bAbcam, Cambridge, MA, UK
solution for 12 hours, washed for 20 minutes, dehydrated 
in ethyl alcohol, washed in xylene and embedded in 
paraffin blocks. Three-μm sections were obtained and 
submitted for routine hematoxylin-eosin staining. For 
immunohistochemical staining, another 3-μm tissue 
sections were prepared. Immunohistochemical staining 
was performed with anti-N-cadherin and Twist antibody, 
respectively. The characteristics of primary antibodies 
were summarized to Table 1. 
Antigen retrieval for N-cadherin and Twist was 
performed by boiling the slides in the citrate buffer (pH 
6.0, Invitrogen, CA, USA) in 45 min, and then cooling 
for 25 min at RT, according to the manufacturer's 
instructions.
After antigen retrieval, the slides were washed 
thoroughly in phosphate buffered saline (PBS, pH 7.4) 
for 5 min 3 times each and incubated with H2O2 
solution and blocking solution for 20 min at room 
temperature in a humid chamber, respectively. And then, 
N-cadherin and Twist antibody were diluted with 3% 
bovine serum albumin solution, the slides were incubated 
overnight at 4℃ with primary antibody, respectively. 
Visualization of bound antibodies was performed by 
using a CSA II biotin free tyramide signal amplification 
system (Dako, Carpinteria, CA, USA), which contain 
fluorescyl-tyramide complex and poly HRP conjugate  
(Invitrogen), according to the manufacturer󰡑s instructions.
The slides were visualized with 3, 3'-diamonobenzidine 
tetrahydrochloride (Vector laboratories, Burlingame, CA, 
USA), counterstained with Mayer's hematoxylin, dehydrated 
in ethanol, cleared in xylene and mounted using Malinol. 
And then, the slides were examined under light 
microscopy (Olympus, BH-2, Tokyo, Japan).
4. Evaluation of immunohistochemical stain
For each slide, 5 non-overlapping fields were randomly 
selected, and photographed using light microscopy with 
a digital camera (Olympus, BX51T, Tokyo, Japan, ×100). 
The expressions of N-cadherin and Twist antibody were 
evaluated in a semi-quantitative manner15). Levels of 
immunore-activity (LI) were graded into four easily 
reproducible subgroups: (a) No detectable expression 
(Grade 0), (b) positive expression in less than 30% of 
cells (Grade 1) (c) positive expression in 30-50% of cells, 
indicating immunopositive subpopulations (Grade 2), and 
(d) positive expression in greater than 50% of cells 
(Grade 3). The Twist expression appeared in the nucleus 
was considered positive.
5. Statistical Analysis
Statistical analysis was performed by chi-sqaure test to 
compare the expression of N-cadherin and Twist and 
analyze the differences between primary OSCC and 
metastatic OSCC. In addition, the correlations between 
N-cadherin and Twist and clinicopathologic parameters 
(age, gender, survival months, TNM stage, recurrence, 
lymph node metastasis) of OSCC patients were determined 
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by Spearman Correlation Coefficient. The Kaplan-Meier 
method was used for survival analysis grouping with 
N-cadherin expression and metastasis. Statistical analysis 
was performed using the Window PASW (Predictive 
Analytics SoftWare) version 18.0 (SPSS Inc, NY, USA). A 
p-value ≤ 0.05 was considered statistically significant.
III. Result 
1. The characteristics of OSCC patients
The OSCC patient age ranged from 31 to 78 years 
and most OSCC patients were distributed in the fifty and 
sixty (Table 2). The male:female ratio of OSCC patients 
was 3:1 (Table 3). Clinicopathological features of the 
OSCC patients were summarized in Table 4.
2. N-cadherin and Twist Expression in OSCC 
patients
The rate of high Twist expression was 87.3% and that 
of N-cadherin was 70.4% in OSCC. There was no 
difference between the N-cadherin and Twist expression 
of primary OSCC and metastatic OSCC. Conversely, the 
expression of N-cadherin in metastatic OSCC increased 
than in corresponding primary OSCC (p<0.05, Fig. 1, 2). 
The spearman correlation coefficiency between Twist and 
N-cadherin was calculated as 0.228 (p<0.05).
3. Correlation between N-cadherin expression 
and the clinicopathological parameters of 
OSCC patients
To analyze the association with the immunoreactivity 
of N-cadherin and Twist and the clinicopatholgical 
parameters of OSCC patients, Spearman's Correlation 
Coefficient was employed for correlation analysis. There 
was a significant correlation between the immunoreactivity 
of N-cadherin and regional lymph node metastasis and 
survival of OSCC patients (Table 5). In case of Twist, 
there was significant correlation between the Twist 
expression and gender and recurrence of OSCC patients.
4. Relationship between N-cadherin and Twist 
expression and survival months
In case of lower N-cadherin expression, survival 
months did not correlate with lymph node metastasis. In 
contrast, in case of higher N-cadherin expression, survival 
months were found to be associated with lymph node 
metastasis (p<0.05, Fig. 3).
IV. Discussion 
EMT is characterized by loss of epithelial polarity and 
increasing cell motility in tumor cells16). It is thought that 
EMT plays critical role in invasion and metastasis in 
tumorigenesis16). During EMT process, the change of 
several transcriptional factors expression such as Twist, 
Snail, and SIP1, and Twist is reported to pivotal role in 
mesenchymal transition of epithelial cells13,17). Twist is 
involved in relatively early stage of tumorigenesis, and 
known as to activate EMT process, possibly through the 
regulation of cadherin expression12,17). Researches on EMT 
mechanism are now emerging as a new tool for 
identification the genes involved in tumor progression. 
There were few studies on N-cadherin and Twist 
expression in OSCC. Mariotti reported that N-cadherin 
expression was found in membrane and cytoplasm of 
head and neck carcinoma cells18). In head and neck 
squamous cell carcinoma, high expression of N-cadherin 
was examined by immunohistochemical detection and 
significant correlated with invasion9). Thus, immunohistochemical 
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Table 2. Age distribution of OSCC patients
Age
OSCC cases
Primary Metastatic 
20-29 Years 1
30-39 Years 3
40-49 Years 8 1
50-59 Years 19 3
60-69 Years 15 1
70-79 Years 7 1
80-89 Years 1
Unknown 4
Total 58 6
Table 3. The gender distribution of OSCC patients
Gender
OSCC cases
Primary Metastatic  
M 40 5
F 14 1
Unknown 4
Total 58 6
Table 4. The clinicopathological parameters of studied oral squamous cell carcinoma (OSCC) patients
OSCC case
Primary Metastatic 
Survival
~12 months 7 3
13~24 months 11
25~36 months 8 1
37~48 months 5 1
49~60 months 6
61~72 months 7
73~ months 8 1
Unknown 6
TNM stage
Stage 0 1
Stage Ⅰ 7
Stage Ⅱ 8
Stage Ⅲ 9 2
Stage Ⅳ 27 4
Unknown 6
Recurrence
Recur (+) 2 1
Recur (-) 51 5
Unknown 5
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Table 5. The relationship between immuohistochemical results and clinicopathological parameters in OSCC patients
Clinical parameters N-cadherin Twist 
Primary Metastatic Primary Metastatic 
Age Spearman Co. 0.104 0.345 0.084 0.340p value .089 .078 .169 .083
Gender Spearman Co. 0.058 -.380 0.064 -0.438p value .347 .051 .297 .022
Recurrence Spearman Co. -0.066 -0.014 0.135 -0.245p value .287 .946 .028 .218
TNM stage Spearman Co. -0.058 -0.051 0.038 0.002p value .353 .801 .543 .991
LN metastasis Spearman Co. -0.378 0.037p value .000 .531
Survival Spearman Co. .085 -0.490 -0.064 0.062p value .174 .010 .302 .760
A CB
FED
  
Fig. 1. N-cadherin and Twist immunohistochemical staining of primary OSCC (A, B, C and D) and metastatic OSCC (E and F). (X100) 
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Fig. 2. The expression of N-cadherin and Twist protein in primary OSCC and metastatic OSCC (A: primary OSCC and metastatic 
OSCC, B: primary OSCC and corresponding metastatic OSCC).  
* : p<0.05
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Fig. 3. Kaplan-Meier overall survival curves according to the expression of N-cadherin and lymph node metastasis (A: low N-cadherin 
expression, B: high N-cadherin expression).
detection of these proteins can be a useful tool in the 
EMT research.
In the present study, there wasn't difference between 
the N-cadherin and Twist expression of primary OSCC 
and metastatic OSCC. Furthermore, no significant correlation 
between Twist and patient's age, TNM stage, lymph 
node metastasis and survival were found. Instead, a 
weak positive correlation between Twist and recurrence 
was detected. Thus, it was thought that Twist-induced 
EMT didn't show any association with OSCC. Gasparotto 
suggested that Twist1 was signi- ficantly overexpressed in 
head and neck cancer, but failed to correlate with 
clinicopathological parameters5). Additionally, Nakashima 
reported that Twist expression varied among human lung 
cancer cell lines12), thus, it is thought to show variable 
Twist expression depending on the type of tumor. 
However, further studies are now needed which attempt 
to analyze the exact role of Twist-induced EMT in OSCC 
with larger samples. 
Interestingly, the N-cadherin expression increased in 
metastatic OSCC, as compared to corresponding primary 
tumor. Wang reported that E-cadherin was suppressed in 
oral tongue squamous cell carcinoma19). Cadherin switching 
is known to reflect EMT20). In laryngeal carcinoma, 
alteration of Twist had an effect on the expression of 
N-cadherin21). Although there was a significant correlation 
between N-cadherin and twist expression, whether Twist 
regulate N-cadherin in OSCC is not clear. 
Tumor metastasis is very complex process, and various 
factors involve in each step of the process of metastasis22). 
Nguyen suggested that N- cadherin might play an 
important role in metastasis of spindle cell carcinoma of 
head and neck region20). Additionally, N-cadherin 
expressing MCF-7 cell induced the metastatic potential11). 
The gain of N-cadherin may trigger interaction with 
surrounding fibroblasts and facilitate metastasis23). Thus, it 
is thought that increased N-cadherin expression may play 
important role in the metastasis of OSCC. However our 
result demonstrated that there was a negative correlation 
between N-cadherin expression and lymph node metastasis. 
Therefore, in our cases, it is thought that N-cadherin 
induced EMT doesn't have a significant influence on the 
metastasis of OSCC.
A notable finding of our research is the poor 
prognosis in OSCC cases showing high expression of N- 
cadherin. In OSCC, up-regulated N-cadherin had a signi- 
ficant correlation with worst prognosis24). Furthermore, in 
bladder cancer, high expression of N-cadherin was 
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suggested to be a prognostic factor25). It is reported that 
N-cadherin itself may promote invasion of head and 
neck carcinoma cells9). N-cadherin interact with various 
signaling pathways, such as epidermal growth factor, 
platelet- derived growth factor and fibroblast growth 
factor9,26). It is needed to carry out further researches on 
the detailed mechanism of N-cadherin regulation as well 
as exact role in oral progression. Taken together, we 
suggest that N- cadherin can be a new candidate of 
prognostic marker of OSCC. 
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